Reduced PTPRD expression has been reported in nasopharyngeal carcinoma (NPC), whereas increased PTPRD levels enhance the sensitivity of NPC cells to radiotherapy by decreasing STAT3 phosphorylation [213]. The gene discussed is PTPRD; the disease is nasopharyngeal carcinoma.